Back to top
Top
U.S. flag

An official website of the United States government

Proportion measure

Year CMS eCQM ID Measure Name
2025 CMS347v8 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2023 CMS349v5 HIV Screening
2024 CMS349v6 HIV Screening
2025 CMS349v7 HIV Screening
2023 CMS506v5 Safe Use of Opioids - Concurrent Prescribing
2024 CMS506v6 Safe Use of Opioids - Concurrent Prescribing
2025 CMS506v7 Safe Use of Opioids - Concurrent Prescribing
2023 CMS645v6 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2024 CMS645v7 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2025 CMS645v8 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
2023 CMS646v3 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2024 CMS646v4 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2025 CMS646v5 Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer
2023 CMS771v4 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
2024 CMS771v5 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
2025 CMS771v6 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
2023 CMS816v2 Hospital Harm - Severe Hypoglycemia
2024 CMS816v3 Hospital Harm - Severe Hypoglycemia
2025 CMS816v4 Hospital Harm - Severe Hypoglycemia
2024 CMS819v2 Hospital Harm - Opioid-Related Adverse Events

We want your feedback

For technical questions about eCQMs, please log in to the ONC Project Tracking System, specifically the eCQM Issue Tracker.

eCQI Resource Center Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.